Follistatin-315
Also known as: FS-315, FST-315
Overview
315-amino acid isoform of follistatin with preferential selectivity for myostatin over activin. Considered more specific for muscle growth with less impact on the reproductive and endocrine axes.
Protein of 315 amino acids. Shorter isoform of Follistatin-344.
Molecular Weight
~35 kDa
Half-life
~4-8 hours
Administration Route
Subcutaneous
Category
Specialized Research
Mechanism of Action
- Selective myostatin inhibition
- Lower affinity for activin compared to FS-344
- Promotion of muscle hypertrophy
- Less interference with the reproductive hormonal axis
Dosage Protocol
Data compiled from the literature. This does not constitute medical advice.
| Parameter | Value |
|---|---|
| Dose | 100-200 mcg per injection |
| Frequency | Once daily |
| Timing | Morning or post-workout |
| Duration | 10-30 days |
Reported Side Effects
Adverse effects described in the literature. Severity and frequency vary between individuals.
- Injection site redness
- Fatigue
- Headache
Presentations & Preparation
Vials of Follistatin-315 found in the research market:
Reconstitution
- Diluent: Bacteriostatic water
- Volume: 1 ml per 1 mg vial
- Inject diluent slowly
- Gently swirl
- Immediate use recommended
Storage
- Lyophilized: Frozen -20°C (long-term)
- Reconstituted: Refrigerated 2-8°C (up to 7 days)
- Avoid freeze/thaw cycles
- Protect from light
Related Peptides
Aviptadil
50-150 mcg per administration (IV or subcutaneous) · 1-3 times daily per protocol
B7-33
100-500 mcg per injection (subcutaneous) · Once daily
Bronchogen
5-10 mg per day via subcutaneous injection · Once daily
Cardiogen
5-10 mg per day subcutaneously · Once daily
Chonluten
5-10 mg per day subcutaneously · Once daily
Crystagen
5-10 mg per day via subcutaneous injection · Once daily